Coya Therapeutics Inc (COYA)
8.79
+0.29
(+3.41%)
USD |
NASDAQ |
May 17, 16:00
8.79
0.00 (0.00%)
After-Hours: 20:00
Coya Therapeutics Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
Date | Value |
---|---|
December 31, 2023 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2023
--
Maximum
Dec 2023
--
Average
--
Median
Dec 2023
Debt to Equity Ratio Benchmarks
Virpax Pharmaceuticals Inc | -- |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.00 |
IGC Pharma Inc | 0.0152 |
NovaBay Pharmaceuticals Inc | 6.294 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 37.39M |
Total Liabilities (Quarterly) | 5.000M |
Shareholders Equity (Quarterly) | 32.39M |
Current Ratio | 8.644 |